Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis

ALTINIŞIK F, ATAŞ B, Avci FG (2021)
International Journal of Secondary Metabolite 8(2): 104-112.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
ALTINIŞIK, Fatma; ATAŞ, Başak; Avci, Fatma GizemUniBi
Abstract / Bemerkung

Antibiotic resistance has become a global health problem for humankind. Improper use of antibiotics resulted in the increasing evolved bacterial resistance to them. There are different types of bacterial resistance mechanisms including efflux pumps. To overcome the efflux pump activity on the drugs, combinatorial therapy of the existing antimicrobials with natural products is a promising insight to prevent increasing multidrug resistance. In this study, the inhibitory action of a plant-derived molecule silibinin on efflux pumps of Bacillus subtilis was investigated. The cellular effect of silibinin was investigated using minimum inhibitory concentration and growth studies. In addition, the efflux pump action of silibinin was monitored by ethidium bromide accumulation assay on the organism. According to results, silibinin has a MIC value between 100-200 µgmL-1 on microplate assay and 100 µgmL-1 of silibinin inhibited the cell growth. Ethidium bromide accumulation assays were performed at a safe silibinin range (25 and 50 µgmL-1) for eliminating the cell death, and ethidium bromide accumulation was increased with the increasing silibinin concentration. Ethidium bromide accumulation and growth results proved that silibinin has significant efflux pump inhibitor activity on Bacillus subtilis cells and silibinin is a promising inhibitor candidate to eliminate bacterial resistance mechanism.

Stichworte
Silibinin; Efflux pump inhibitor; Bacillus subtilis; Multidrug resistance
Erscheinungsjahr
2021
Zeitschriftentitel
International Journal of Secondary Metabolite
Band
8
Ausgabe
2
Seite(n)
104-112
eISSN
2148-6905
Page URI
https://pub.uni-bielefeld.de/record/2991507

Zitieren

ALTINIŞIK F, ATAŞ B, Avci FG. Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis. International Journal of Secondary Metabolite. 2021;8(2):104-112.
ALTINIŞIK, F., ATAŞ, B., & Avci, F. G. (2021). Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis. International Journal of Secondary Metabolite, 8(2), 104-112. https://doi.org/10.21448/ijsm.865031
ALTINIŞIK, Fatma, ATAŞ, Başak, and Avci, Fatma Gizem. 2021. “Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis”. International Journal of Secondary Metabolite 8 (2): 104-112.
ALTINIŞIK, F., ATAŞ, B., and Avci, F. G. (2021). Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis. International Journal of Secondary Metabolite 8, 104-112.
ALTINIŞIK, F., ATAŞ, B., & Avci, F.G., 2021. Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis. International Journal of Secondary Metabolite, 8(2), p 104-112.
F. ALTINIŞIK, B. ATAŞ, and F.G. Avci, “Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis”, International Journal of Secondary Metabolite, vol. 8, 2021, pp. 104-112.
ALTINIŞIK, F., ATAŞ, B., Avci, F.G.: Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis. International Journal of Secondary Metabolite. 8, 104-112 (2021).
ALTINIŞIK, Fatma, ATAŞ, Başak, and Avci, Fatma Gizem. “Evaluation of silibinin as an efflux pump inhibitor in Bacillus subtilis”. International Journal of Secondary Metabolite 8.2 (2021): 104-112.
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Suchen in

Google Scholar